MoneyWorks4Me

Encube Ethicals files preliminary papers with SEBI to raise Rs 3,000 crore via IPO

04 Aug 2026 Evaluate

Encube Ethicals has filed preliminary papers with capital markets regulator Securities and Exchange Board of India (SEBI) to raise Rs 3,000 crore through an Initial Public Offering (IPO). The company's maiden IPO is completely an offer for sale by the promoter Mehul Madhusudan Shah and existing shareholder Frontier Investment Holdings. 

Since it's an OFS, the company will not receive any proceeds from the public issue, instead funds will go to selling shareholders. JM Financial, Axis Capital, and Kotak Mahindra Capital Company are the book running lead managers to the issue. The shares are proposed to be listed on the BSE and NSE.   

Encube Ethicals is a global specialty pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms. 


Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: